documents: FDA-1976-N-0519-0105
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1976-N-0519-0105 | FDA | FDA-1976-N-0519 | Tab R - FDA Summary Basis of Approval, "Medical Officer's Review of Supplemental NDA", for Approval of NDA Supplement Permitting Phenergan VC to be Sold OTC re Comment Wyeth-Ayerst Laboratories Divison of American Home Products Corporation | Supporting & Related Material | Reply Comment (RC) | 2011-04-25T04:00:00Z | 2011 | 4 | 2018-02-14T16:53:17Z | 0 | 0 | 0900006480c37549 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref